Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au… - Heart rhythm, 2010 - Elsevier
BACKGROUND: Cellular replacement strategies using embryonic stem cells (ESCs) and
their cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …
被引用次数：91 相关文章

[引用][C] Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au… - Heart Rhythm, 2010 - cir.nii.ac.jp

Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au… - Heart Rhythm, 2010 - infona.pl
Cellular replacement strategies using embryonic stem cells (ESCs) and their cardiac
derivatives are emerging as novel experimental therapeutic paradigms for the treatment of …

Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au… - Heart Rhythm, 2010 - hub.hku.hk
Background Cellular replacement strategies using embryonic stem cells (ESCs) and their
cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …

Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai, KW Au… - Heart Rhythm, 2010 - europepmc.org
Background Cellular replacement strategies using embryonic stem cells (ESCs) and their
cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …

Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai… - Heart …, 2010 - heartrhythmjournal.com
Background Cellular replacement strategies using embryonic stem cells (ESCs) and their
cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …

Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai… - Heart …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Cellular replacement strategies using embryonic stem cells (ESCs) and their
cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …
[PDF] academia.edu

[PDF][PDF] Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, RA Li, HF Tse - Heart Rhythm, 2010 - academia.edu
BACKGROUND Cellular replacement strategies using embryonic stem cells (ESCs) and
their cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …

Proarrhythmic risk of embryonic stem cell–derived cardiomyocyte transplantation in infarcted myocardium

SY Liao, Y Liu, CW Siu, Y Zhang, WH Lai… - Heart …, 2010 - heartrhythmjournal.com
Background Cellular replacement strategies using embryonic stem cells (ESCs) and their
cardiac derivatives are emerging as novel experimental therapeutic paradigms for the …